Publications by authors named "Simran Chandani"

Claim this Profile
C
Crosslinked hydroxypropyl-β-cyclodextrin nanoparticles for improved efficacy of venetoclax against triple negative breast cancer.
Simran Chandani, Sayali Dighe, Oly Katari, Vivek Yadav, Sanyog Jain

Int J Pharm· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis